Invention patent: The invention relates to an R & D and preparation patent for repairing brain nerve problems by using brain multi-target reckoning combined response directed telomerase.
The scope of application is limited to the nerve repair of the brain or the reflex areas of the brain and other organs, supplement the lack of substances in the brain nerves, and then adjust the brain nerves or some brain reactive substances related to them. The effects that can be produced are cerebral cortical balance, cognitive improvement of learning ability, memory improvement, repair of brain atrophy problems, repair of pituitary secretion function, repair of neuronal conduction function, repair of abnormal behavior of brain nerve degeneration, brain neurodegenerative repair, neurasthenia and other obvious therapeutic expression.
Be used for: Can be cured, neurasthenia, neuropathy, nerve conduction disruption, memory loss, brain substance deficiency, ear nerve repair, cerebellar atrophy, prevention of brain diseases that do not match age, fetal brain development during pregnancy, brain development of infants during lactation, brain development of children, brain fatigue of adults, brain state of young, can be excellent expression.
Component:Targeting telomerase fusion melanase holoenzyme active powder with 4-6-7-9 family segment of gene protein, Whole brain neuron membrane phospholipase, Brain cell metabolic enzyme, Brain cell energy enzyme, Yeast active extract 9 layers, Cerebral oxygenin, Ice flower alcohol enzyme molecule (D-Ice flower alcohol dehydrogenase) (specific properties of nervous system response).
Net content:200 tablets.
Taking method:Take 2 to 9 tablets daily, or follow the instructions of the relevant doctors.
Put it in a cool and dry place and take it during the shelf life. See the sealing card for the date.